US FDA inspects Vishakhapatnam facility of Solara Active Pharma
US Food and Drug Administration US FDA has successfully completed the inspection of the multipurpose API manufacturing facility of Solara Active Pharma Scienc
Stay updated with breaking news from Zero Form. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US Food and Drug Administration US FDA has successfully completed the inspection of the multipurpose API manufacturing facility of Solara Active Pharma Scienc
The US Food and Drug Administration (FDA) completes inspection of Solara Active Pharma Sciences' API manufacturing facility in Visakhapatnam, Andhra Pradesh, with no observations. Solara confirms compliance with FDA standards. The facility, dedicated to Ibuprofen API production, marks Solara's second successful FDA inspection. The company aims for global market expansion with FDA-approved facilities.
US FDA inspected the the multi-product facility between and found it to be in an “acceptable state of compliance”, the company said
Pokémon TCG Japan’s Ruler of the Black Flame, the basis for the next English-language set, includes a Palafin Illustration Rare.
USFDA clears Solara Active's Visakhapatnam facility. The US Food and Drug Administration has cleared Solara Active Pharma Sciences Ltd's new multipurpose active pharmaceutical ingredient manufacturing facility at Visakhapatnam, Andhra Pradesh, with no observation, the company said in an exchange filing.